The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder characterized by incompletely reversible airflow obstruction. Bacterial infection of the lower respiratory tract contributes to approximately 50% of COPD exacerbations. Even during periods of stable lung function, the lung harbors a community of bacteria, termed the microbiome. The role of the lung microbiome in the pathogenesis of COPD remains unknown. The COPD lung microbiome, like the healthy lung microbiome, appears to reflect microaspiration of oral microflora. Here we describe the COPD lung microbiome of 22 patients with Moderate or Severe COPD compared to 10 healthy control patients. The composition of the lung microbiomes was determined using 454 pyrosequencing of 16S rDNA found in bronchoalveolar lavage fluid. Sequences were analyzed using mothur, Ribosomal Database Project, Fast UniFrac, and Metastats. Our results showed a significant increase in microbial diversity with the development of COPD. The main phyla in all samples were Actinobacteria, Firmicutes, and Proteobacteria. Principal coordinate analyses demonstrated separation of control and COPD samples, but samples did not cluster based on disease severity. However, samples did cluster based on the use of inhaled corticosteroids and inhaled bronchodilators. Metastats analyses demonstrated an increased abundance of several oral bacteria in COPD samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The microbiome, including the mycobiome, is largely dependent on the area of the body, and may be altered during disease (Pragman et al., 2010; Mukherjee et al., 2014; Gouba and Drancourt, 2015).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Pragman et al., 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“uchime implemented in mothur [37] were used to truncate low-quality sequences and remove chimeras, respectively.”
MethodMuyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429 · cited 1×
“PCR amplification using 16S rRNA gene primers specific to the constant regions flanking the V3 region [35,36] was performed using 20 cycles.”
MethodMultiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,875 · cited 1×
“For PCoA analyses, sequences were dereplicated and ClustalW was used to align the dereplicated sequences [38].”
MethodThe Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762 · cited 2×
“To minimize effects of random sequencing errors, we used RDP Pipeline [4] to eliminate (a) sequences that did not appropriately match the PCR primer and the barcode at the beginning of a read, (b) sequence reads with ,50 bases after the proximal PCR primer if they terminated before reaching the distal”
MethodDewhirst, F. E., Chen, T., Izard, J., Paster, B. J., Tanner, A. C. R., Yu, W.-H., Lakshmanan, A., & Wade, W. G. (2010) · Journal of Bacteriology · doi:10.1128/jb.00542-10 · Cited by 3,352
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824 · cited 1×
“The microbiome in early childhood may play a role in the development of asthma [8], while specific components of the microbiome are associated with chronic asthma in adulthood [9].”
BackgroundImproved extraction of PCR-quality community DNA from digesta and fecal samples
Yu, Z., & Morrison, M. (2004) · BioTechniques · doi:10.2144/04365st04 · Cited by 1,664 · cited 1×
“We used a previously described protocol [33] for DNA isolation that included bead beating to lyse bacterial cells, followed by precipitation with isopropanol and digestion with RNase.”
MethodStatistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,586 · cited 1×
“Metastats [40] was used to detect differentially abundant taxa using taxonomic data from RDP Classifier controlling the false discovery rate at 10% for each level of the taxonomy.”
MethodMicrobiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502 · cited 1×
“showed that the mouse microbiome helps regulate the immune function necessary to respond to Influenza A virus infection [12].”
BackgroundTopographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract
Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0655oc · Cited by 1,144 · cited 4×
“[7] who noted that the bacteria in the BALF arise from upper respiratory tract bacteria, likely through a combination of microaspiration and bronchoscopic carryover during sampling.”
BackgroundInfluential
Cited by
Items 101–200 of 445
Household air pollution and the lung microbiome of healthy adults in Malawi: a cross-sectional study
Rylance, J., Kankwatira, A., Nelson, D. E., Toh, E. C., Day, R. B., Lin, H., Gao, X., Dong, Q., Sodergren, E. J., Weinstock, G. M., et al. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0803-7 · Cited by 77
“Reduced diversity of the lung microbiome has been seen in disease states, such as COPD, [24] and with medical treatments, such as inhaled corticosteroids [28].”
BackgroundRole of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Paudel, K. R., Dharwal, V., Patel, V. K., Galvão, I., Wadhwa, R., Malyla, V., Shen, S., Budden, K. F., Hansbro, N. G., Vaughan, A., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00554 · Cited by 84
Luna, P. N., Hasegawa, K., Ajami, N. J., Espinola, J. A., Henke, D., Petrosino, J. F., Piedra, P. A., Sullivan, A. F., Camargo, C. A., Shaw, C. A., et al. (2018) · Microbiome · doi:10.1186/s40168-017-0385-0 · Cited by 76
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
Opron, K., Begley, L., Erb‐Downward, J. R., Freeman, C. M., Madapoosi, S., Alexis, N. E., Barjaktarević, I., Barr, R. G., Bleecker, E. R., Bowler, R. P., et al. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00185-9 · Cited by 78
Wang, Z., Liu, H., Wang, F., Yang, Y., Wang, X., Chen, B., Stämpfli, M. R., Zhou, H., Shu, W., Brightling, C. E., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01758 · Cited by 76
Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
Xu, N., Wang, L., Li, C., Ding, C., Li, C., Fan, W., Chen, C., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-156 · Cited by 76
Kolwijck, E., & van de Veerdonk, F. L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344404 · Cited by 69
Briard, B., Mislin, G. L. A., Latgé, J.-P., & Beauvais, A. (2019) · Journal of Fungi · doi:10.3390/jof5020048 · Cited by 69
“fumigatus is never alone, but is always present in microbial communities [8,9].”
BackgroundChiu, Y.-C., Lee, S.-W., Liu, C.-W., Lan, T.-Y., & Wu, L. S.-H. (2022) · Respiratory Research · doi:10.1186/s12931-022-01928-8 · Cited by 71
Simpson, J. L., Baines, K. J., Horvat, J. C., Essilfie, A., Brown, A. C., Tooze, M., McDonald, V. M., Gibson, P. G., & Hansbro, P. M. (2016) · Respirology · doi:10.1111/resp.12734 · Cited by 73
Avalos, M., Alin, T., Métayer, C., Thiébaut, R., Enaud, R., & Delhaès, L. (2022) · Respiratory Research · doi:10.1186/s12931-022-02132-4 · Cited by 72
Sputum microbiota in moderateversussevere patients with COPD
Galiana, A., Aguirre, E., Rodríguez, J. C., Mira, Á., Santibáñez, M., Candela, I., Llavero, J., Garcinuño, P., Martínez-López, F. J., Ruiz, M., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00191513 · Cited by 68
mbImpute: an accurate and robust imputation method for microbiome data
Jiang, R., Li, W. V., & Li, J. J. (2021) · Genome biology · doi:10.1186/s13059-021-02400-4 · Cited by 69
“Existing 384 studies have attempted to address this issue via calibrated sequencing operations [2, 3, 6] and 385 computational methods [4,5].”
BackgroundThe composition of lung microbiome in lung cancer: a systematic review and meta-analysis
Najafi, S., Abedini, F., Jamalkandi, S. A., Shariati, P., Ahmadi, A., & Fesharaki, M. G. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02375-z · Cited by 70
Merenstein, C., Bushman, F. D., & Collman, R. G. (2022) · Microbiome · doi:10.1186/s40168-022-01342-8 · Cited by 68
Airway Microbiota as a Modulator of Lung Cancer
Goto, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093044 · Cited by 70
Janson, C., Stratelis, G., Miller‐Larsson, A., Harrison, T. W., & Larsson, K. (2017) · International Journal of COPD · doi:10.2147/copd.s143656 · Cited by 63
“52,53 Importantly, according to the “keystone pathogen” hypothesis, even small alterations in the abundance of a few bacterial species can have great effects on microbial community and subsequently modify disease status.”
Treatable Traits in COPD – A Proposed Approach
Cardoso, J., Ferreira, A. J., Guimarães, M., Oliveira, A. S., Simão, P., & Sucena, M. (2021) · International Journal of COPD · doi:10.2147/copd.s330817 · Cited by 68
“of the microbiota varies along the bronchial tree and according to the stages of severity in COPD.(53,54) More”
BackgroundSputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD
Su, J., Liu, H., Tan, X.-L., Ji, Y. I., Jiang, Y., Prabhakar, M., Rong, Z., Zhou, H., & Zhang, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130736 · Cited by 62
“In contrast to most previous studies, which described particular community compositions during exacerbation [10,24], the vertical sampling employed in our experimental design allowed us to more closely follow the day-to-day changes in sputum microbiota during hospital stays.”
ResultThe lung microbiome and exacerbations of COPD
Dy, R., & Sethi, S. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000268 · Cited by 60
“Interestingly, the study observed that the microbiome of patients on inhaled corticosteroids and bronchodilators are different from patients who were not on these medications [18].”
BackgroundMillares, L., Pascual-Guàrdia, S., Montón, C., García-Núñez, M., Lalmolda, C., Faner, R., Casadevall, C., Setó, L., Capilla, S., Moreno, A., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0867-x · Cited by 62
Bingula, R., Filaire, E., Molnar, I., Delmas, E., Berthon, J., Vasson, M., Bernalier‐Donadille, A., & Filaire, M. (2020) · Respiratory Research · doi:10.1186/s12931-020-01392-2 · Cited by 74
“) [63] or pulmonary complications (Propionibacteriaceae, Enterococcaceae) [64–66].”
Pragman, A. A., Berger, J. P., & Williams, B. J. (2016) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000108 · Cited by 69
“Lung microbiota diversity appears to be maintained in mild, moderate, and severe COPD, but this association may be primarily driven by age or medication use.(37,44,58) Diversity appears to be decreased in very severe COPD.”
BackgroundSelf-citationYang, C.-Y., Li, S.-W., Chin, C.-Y., Hsu, C., Lee, C., Yeh, Y., & Wu, K.-A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02788-4 · Cited by 67
Respiratory Viral and Bacterial Exacerbations of COPD—The Role of the Airway Epithelium
Love, M. E., & Proud, D. (2022) · Cells · doi:10.3390/cells11091416 · Cited by 65
Page, L. K., Staples, K. J., Spalluto, C. M., Watson, A., & Wilkinson, T. M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653969 · Cited by 67
Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics
Shi, C. Y., Yu, C.-H., Yu, W. Y., & Ying, H. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/9278441 · Cited by 65
Sriram, K. B., Cox, A. J., Clancy, R. L., Slack, M., & Cripps, A. W. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1329274 · Cited by 64
“Currently only a few studies have used non-culture-based molecular microbiology techniques to study the lung microbiome in COPD patients (Hilty et al. 2010; Erb-Downward et al. 2011; Pragman et al. 2012; Sze et al. 2012; Zakharkina et al. 2013).”
BackgroundPragman, A. A., Knutson, K. A., Gould, T. J., Isaacson, R. E., Reilly, C., & Wendt, C. H. (2019) · Respiratory Research · doi:10.1186/s12931-019-1080-4 · Cited by 60
“[17, 38] We therefore included age as a predictor in our alpha diversity linear mixed models.”
MethodSelf-citationCameron, S. J. S., Lewis, K. E., Huws, S., Lin, W., Hegarty, M., Lewis, P. D., Mur, L. A. J., & Pachebat, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149095 · Cited by 63
“More recent work, with a larger cohort of moderate and severe COPD patients, suggested increased microbial diversity in more severe COPD [5].”
BackgroundThe microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection
Adami, A. J., & Cervantes, J. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.07.004 · Cited by 62
“Facing the clear evidence of the inadequacy of culture-based studies to exclude the presence of microorganisms, a number of investigations have conclusively demonstrated that the lung harbors a community of microorganisms even in the healthy state [15,21,22,38,41,42,49,61,63,106,115,121].”
BackgroundWu, X., Chen, J., Xu, M., Zhu, D., Wang, X., Chen, Y., Wu, J., Cui, C., Zhang, W., & Yu, L. (2017) · Journal of Oral Microbiology · doi:10.1080/20002297.2017.1324725 · Cited by 59
“robe which can be isolated from the human intestine [35], brain abscesses [36], and bronchoalveolar lavage fluid (BALF) from COPD patients [14].”
BackgroundResultLung Microbiota and Its Impact on the Mucosal Immune Phenotype
Wu, B. G., & Segal, L. N. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0005-2016 · Cited by 61
“%) were shared among all three groups (116).”
BackgroundExploring the microbiome in health and disease: Implications for toxicology
Scotti, E., Boué, S., Sasso, G. L., Zanetti, F., Belcastro, V., Poussin, C., Sierro, N., Battey, J. N. D., Gimalac, A., Ivanov, N. V., et al. (2017) · Toxicology Research and Application · doi:10.1177/2397847317741884 · Cited by 97
The bacterial microbiota in inflammatory lung diseases
Huffnagle, G. B., & Dickson, R. P. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.022 · Cited by 61
“Using techniques of molecular microbial identification, no studies published have suppoerted the claim that the lungs are sterile; bacterial DNA is always detectable in respiratory samples [4, 6-12].”
Martínez, F. J., Vestbo, J., Anderson, J. A., Brook, R. D., Celli, B. R., Cowans, N. J., Crim, C. C., Dransfield, M. T., Kilbride, S., Yates, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1421oc · Cited by 55
Sulaiman, I., Wu, B. G., Chung, M. C., Isaacs, B., Tsay, J.-C. J., Holub, M., Barnett, C. R., Kwok, B., Kugler, M. C., Natalini, J. G., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202210-1865oc · Cited by 60
Eosinophils, probiotics, and the microbiome
Rosenberg, H. F., Masterson, J. C., & Furuta, G. T. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0416-202r · Cited by 54
Dima, E., Kyriakoudi, A., Kaponi, M., Vasileiadis, I., Stamou, P., Koutsoukou, A., Koulouris, N. G., & Rovina, N. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.08.012 · Cited by 59
The relationship between oral health and COPD exacerbations
Baldomero, A. K., Siddiqui, M., Lo, C.-Y., Petersen, A. J., Pragman, A. A., Connett, J. E., Kunisaki, K. M., & Wendt, C. H. (2019) · International Journal of COPD · doi:10.2147/copd.s194991 · Cited by 57
Self-citationPeralbo‐Molina, Á., Calderón-Santiago, M., Priego‐Capote, F., Gámez, B. J., & de Castro, M. D. L. (2016) · Journal of Breath Research · doi:10.1088/1752-7155/10/2/026002 · Cited by 53
Liu, T., Yang, Z., Zhang, X., Han, N., Yuan, J., & Cheng, Y. S. (2017) · 3 Biotech · doi:10.1007/s13205-017-0997-x · Cited by 53
Functional Metagenomics of the Bronchial Microbiome in COPD
Millares, L., Pérez‐Brocal, V., Ferrari, R. G., Gallego, M., Pomares, X., García-Núñez, M., Montón, C., Capilla, S., Monsó, E., & Moyá, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144448 · Cited by 48
Protected sampling is preferable in bronchoscopic studies of the airway microbiome
Grønseth, R., Drengenes, C., Wiker, H. G., Tangedal, S., Xue, Y., Husebø, G. R., Svanes, Ø., Lehmann, S., Aardal, M. E., Hoang, T., et al. (2017) · ERJ Open Research · doi:10.1183/23120541.00019-2017 · Cited by 48
Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males
Lee, S., Kuan, C.-S., Wu, L. S., & Weng, J. T.-Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159066 · Cited by 61
“[32], who identified fewer Proteobacteria and more Firmicutes in the bronchoalveolar lavage fluid (BALF) samples of severe COPD patients relative to their moderate counterparts.”
BackgroundResultInfluentialThe microbiome of the human lower airways: a next generation sequencing perspective
Aho, V. T. E., Pereira, P. A. B., Haahtela, T., Pawankar, R., Auvinen, P., & Koskinen, K. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0074-z · Cited by 47
“It has been suggested that there is no lung “core” microbiome that is similar across study subjects and stable over time, but that the oral microbiome influences the microbial content in lungs [47].”
BackgroundInfluentialSmoking is associated with quantifiable differences in the human lung DNA virome and metabolome
Gregory, A. C., Sullivan, M. B., Segal, L. N., & Keller, B. C. (2018) · Respiratory Research · doi:10.1186/s12931-018-0878-9 · Cited by 46
“Previous studies demonstrated changes in the lung bacteriome in moderate to severe COPD [7, 13], but no differences were found in lung bacterial community structure in healthy smokers without COPD compared to nonsmokers [12].”
BackgroundSpecies-level evaluation of the human respiratory microbiome
Ibironke, O. A., McGuinness, L. R., Lu, S., Wang, Y., Hussain, S., Weisel, C. P., & Kerkhof, L. J. (2020) · GigaScience · doi:10.1093/gigascience/giaa038 · Cited by 49
Lung and Gut Microbiome in COPD
Karakasidis, E., Kotsiou, O. S., & Gourgoulianis, K. I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050804 · Cited by 52
“Furthermore, they pointed out that the development of COPD was associated with a significant increase in microbial diversity [25], which is in contrast with the conclusion of Erb et al.”
BackgroundResultInfluentialRole of pulmonary microorganisms in the development of chronic obstructive pulmonary disease
Liu, J., Ran, Z., Wang, F., Xin, C., Xiong, B., & Song, Z. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1830748 · Cited by 48
“Pulmonary microbial composition in COPD and AECOPD patients Investigation of the pulmonary microbiology of stable COPD patients revealed that the major microbial genus was Streptococcus, Corynebacterium, Prevotella, Rothia, Haemophilus, and Neisseria (Hilty et al. 2010; CabreraRubio et al. 2012; Pragman et al. 2012; P…”
BackgroundInfluentialKelly, N., Winning, L., Irwin, C., Lundy, F. T., Linden, D. A., McGarvey, L. P., Linden, G. J., & Karim, I. A. E. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01757-z · Cited by 56
“Increased microbial diversity in COPD patients has been demonstrated with the identi cation of oral bacteria in their lung microbiome and tissue [15][16].”
BackgroundExacerbation induces a microbiota shift in sputa of COPD patients
Jubinville, É., Veillette, M., Milot, J., Maltais, F., Comeau, A., Lévesque, R. C., & Duchaine, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194355 · Cited by 45
Regulatory T Cells in Respiratory Health and Diseases
Singh, R. V., Alape, D., de Lima, A., Ascanio, J., Majid, A., & Gangadharan, S. P. (2019) · Pulmonary Medicine · doi:10.1155/2019/1907807 · Cited by 47
Sinus Microanatomy and Microbiota in a Rabbit Model of Rhinosinusitis
Cho, D., Mackey, C. S., Pol, W. J. V. D., Skinner, D. F., Morrow, C. D., Schoeb, T. R., Rowe, S. M., Swords, W. E., Tearney, G. J., & Woodworth, B. A. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00540 · Cited by 48
Inhaled corticosteroids and the increased risk of pneumonia: what’s new? A 2015 updated review
Iannella, H. A., Luna, C. M., & WATERER, G. W. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816630208 · Cited by 45
“ COPD patients have alterations in their lung microbiome that may result in chronic infection with potentially pathogenic microorganisms (PPM) [Miravitlles and Anzueto, 2015], and the use of ICS may further alter this microbiome [Pragman et al. 2012; Huang et al. 2014].”
BackgroundEngel, M., Endesfelder, D., Schloter-Hai, B., Kublik, S., Granitsiotis, M. S., Boschetto, P., Stendardo, M., Barta, I., Döme, B., Deleuze, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180859 · Cited by 45
Microbiome in chronic obstructive pulmonary disease
Monsó, E. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.20 · Cited by 39
“In analyses of the respiratory microbiome, however, it must be considered that sputum originates mainly from the in the proximal bronchi, which harbor a flora that have shown clear-cut differences with the microbial pattern found in distal bronchi and the alveolar space (22,23), that is targeted through bronchial biop…”
ResultInhalation Injury: Unmet Clinical Needs and Future Research
Dyamenahalli, K. U., Garg, G., Shupp, J. W., Kuprys, P. V., Choudhry, M. A., & Kovacs, E. J. (2019) · Journal of Burn Care & Research · doi:10.1093/jbcr/irz055 · Cited by 44
Ji, X., Chang, K., Chen, M., Zhu, L., Osman, A., Yin, H., & Zhao, L. (2021) · LWT · doi:10.1016/j.lwt.2021.111224 · Cited by 39
D’Anna, S. E., Balbi, B., Cappello, F., Carone, M., & Stefano, A. D. (2016) · International Journal of COPD · doi:10.2147/copd.s93398 · Cited by 44
“Bacteria in the oral cavity and gastrointestinal tract seed the airways in vulnerable patient populations.(24) Millares et al(29) analyzed paired sputum specimens from patients with COPD at baseline and during exacerbations, and found that exacerbations were associated with a selective increase in the relative abundan…”
The Human Respiratory Microbiome: Implications and Impact
Mitchell, A. B., & Glanville, A. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617441 · Cited by 43
Lipinksi, J. H., Ranjan, P., Dickson, R. P., & O’Dwyer, D. N. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300716 · Cited by 41
Park, J., Shin, N., Shin, I., Kwon, O., Kim, J., Oh, S., Kim, J., & Ahn, K. (2016) · Phytotherapy Research · doi:10.1002/ptr.5686 · Cited by 37
“Most of people with chronic bronchial catarrh have COPD (Silverman et al., 2000; Reilly et al., 2008; Pragman et al., 2012).”
BackgroundThe Role of Respiratory Flora in the Pathogenesis of Chronic Respiratory Diseases
Guo, M.-Y., Chen, H.-K., Ying, H., Qiu, F.-S., & Wu, J.-Q. (2021) · BioMed Research International · doi:10.1155/2021/6431862 · Cited by 46
Wu, D., Hou, C., Li, Y., Zhao, Z., Liu, J., Lu, X., Shang, X., & Xin, Y. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-179 · Cited by 37
“The composition of the lung microbiomes was determined using 454 pyrosequencing of 16S rDNA found in bronchoalveolar lavage fluid (BALF) [34].”
MethodDifferential flora in the microenvironment of lung tumor and paired adjacent normal tissues
Mao, Q., Ma, W., Wang, Z., Liang, Y., Zhang, T., Yang, Y., Xia, W., Jiang, F., Hu, J., & Xu, L. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa044 · Cited by 39
Dysbiosis of human microbiome and infectious diseases
Gupta, A., Singh, V., & Mani, I. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.016 · Cited by 42
Nguyen, M. T., Sharma, A., Wu, W., Gomi, R., Sung, B., Hospodsky, D., Angenent, L. T., & Worgall, S. (2016) · The ISME Journal · doi:10.1038/ismej.2016.76 · Cited by 36
“Particularly for chronic lung diseases with frequent bacterial infections, such as cystic fibrosis (CF) and chronic obstructive pulmonary disease, airway microbiome dynamics have been associated with disease progression (Hunter et al., 2012, Pragman et al., 2012; Huang et al., 2014).”
BackgroundImpact of micro‐environmental changes on respiratory tract infections with intracellular bacteria
Shima, K., Coopmeiners, J., Graspeuntner, S., Dalhoff, K., & Rupp, J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12353 · Cited by 37
The intestinal microbiome and surgical disease
Krezalek, M. A., Skowron, K. B., Guyton, K. L., Shakhsheer, B. A., Hyoju, S. K., & Alverdy, J. C. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.06.001 · Cited by 39
Drengenes, C., Eagan, T., Haaland, I., Wiker, H. G., & Nielsen, R. (2021) · BMC Genomics · doi:10.1186/s12864-020-07252-z · Cited by 38
“Several different 16S rRNA gene variable regions have been targeted in studies of the lung microbiome, including V1 V2 [4, 5], V1 V3 [6–8], V3 V5 [7, 9–13], V3 [14, 15] and V4 [16–19].”
BackgroundChiu, C., Cheng, M., Chiang, M., Wang, C., Tsai, M., & Lin, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-02925-5 · Cited by 36
Brennan, M., McDonnell, M. J., Harrison, M. J., Duignan, N., O'Regan, A. W., Murphy, D. M., Ward, C., & Rutherford, R. M. (2022) · Respiratory Research · doi:10.1186/s12931-022-01947-5 · Cited by 38
“performed a cross-sectional analysis of lung microbiota using BAL samples in patients with moderate to severe COPD and control subjects with respect to GOLD severity classifications [67].”
MethodJacobs, D. M., Ochs‐Balcom, H. M., Zhao, J., Murphy, T. F., & Sethi, S. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00330-18 · Cited by 34
Bacteria in COPD; their potential role and treatment
King, P. T., MacDonald, M., & Bardin, P. G. (2013) · Translational Respiratory Medicine · doi:10.1186/2213-0802-1-13 · Cited by 39
Lim, Y. W., Haynes, M. R., Furlan, M., Robertson, C. E., Harris, J. K., & Rohwer, F. L. (2014) · Journal of Visualized Experiments · doi:10.3791/52117 · Cited by 33
Ren, Y., Su, H., She, Y., Dai, C., Xie, D., Narrandes, S., Huang, S.-J., Chen, C., & Xu, W. W. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.06.11 · Cited by 36
The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
Millares, L., & Monsó, E. (2022) · International Journal of COPD · doi:10.2147/copd.s371958 · Cited by 35
“These changes in the bronchial microbiome may not be paralleled in the lung, because previous work has found higher microbial diversity in bronchoalveolar lavage samples.(14,15) How these changes influence the disease is poorly understood, however, and the possibilities to modify the microbial composition of the lower…”
BackgroundLi, W., Wang, B., Tan, M. H., Song, X., Xie, S., & Wang, C. (2022) · Respiratory Research · doi:10.1186/s12931-022-02246-9 · Cited by 37
“We found that species more enriched in FE or severe group mostly belonged to phylum Proteobacteria, which agrees with the finding of the over-representation of Proteobacteria phylum in severe COPD in other studies [13, 21, 22].”
ResultAlsayed, A. R., Abed, A. I., Khader, H. A., Al-Shdifat, L., Hasoun, L., Al‐Rshaidat, M. M. D., Alkhatib, M., & Zihlif, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044086 · Cited by 39
Opron, K., Begley, L., Erb‐Downward, J. R., Li, G., Alexis, N. E., Barjaktarević, I., Barr, R. G., Bleecker, E. R., Boucher, R. C., Bowler, R. P., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202303-0489oc · Cited by 33
Su, H., McKelvey, J. A., Rollins, D., Zhang, M., Brightsmith, D. J., Derr, J. N., & Zhang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099826 · Cited by 39
“Over the past two decades, numerous culture-dependent and culture-independent microbiome studies have been carried out to characterize the composition and dynamic changes of intestinal microbiota of mammals, domestic poultry, and several wild avian species [11], [12], [13], [14], [15].”
BackgroundLi, H., Wang, Y., Jiang, J., Zhao, H., Feng, X., Zhao, B., & Wang, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00676 · Cited by 32
“And also, it has been demonstrated that Proteobacteria (Ranking second in the list of top 10 predicted microbes) and Firmicutes (Ranking 3rd in the list of top 10 predicted microbes) will increase significantly with the development of COPD ( Pragman et al., 2012).”
BackgroundThe transient but not resident (TBNR) microbiome: a Yin Yang model for lung immune system
Saeedi, P., Salimian, J., Ahmadi, A., & Fooladi, A. A. I. (2015) · Inhalation Toxicology · doi:10.3109/08958378.2015.1070220 · Cited by 32
The Microbiome and Its Implications in Cancer Immunotherapy
Choudhry, H. (2021) · Molecules · doi:10.3390/molecules26010206 · Cited by 31
The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences
Grønseth, R., Haaland, I., Wiker, H. G., Martinsen, E. M. H., Leiten, E. O., Husebø, G. R., Svanes, Ø., Bakke, P. S., & Eagan, T. (2014) · European Clinical Respiratory Journal · doi:10.3402/ecrj.v1.26196 · Cited by 31
“After gentle vortexing of PSB, SVL, and PBAL samples they are cultured on fastidious anaerobic agars, by spread plate technique of 10 and 100 mcl to make a semiquantitative estimate of CFU upon anaerobic culture for 3 days.”
BackgroundInfluentialLazarević, V., Gaïa, N., Emonet, S., Girard, M., Renzi, G., Després, L., Wozniak, H., Marcos, J. Y., Veyrieras, J., Chatellier, S., et al. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00065 · Cited by 34
“Another strategy to cope with low DNA concentration is the use of multiple displacement amplification (MDA) prior to 16S rDNA amplification (Pragman et al., 2012), but MDA may also introduce a representational bias (Marine et al., 2014).”
BackgroundWang, H., Gu, X., Weng, Y., Xu, T., Fu, Z., Peng, W., & Yu, W. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0094-z · Cited by 31
“identified a core pulmonary bacterial microbiome that includes Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus,Veillonella, and Porphyromonas by massively parallel pyrosequencing of bacterial 16S amplicons [35] In another study, the composition of the lung microbiome was determined using 454 pyroseq…”
MethodResultIntestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma
Jiang, H., Li, J., Zhang, B., Huang, R., Zhang, J., Chen, Z., Shang, X., Li, X., & Nie, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01346 · Cited by 34
“A previous study showed that the increased abundance of Proteobacteria was positively correlated with inflammatory diseases (78) such as nonalcoholic fatty liver disease (NAFLD) (79, 80), colitis (81, 82), inflammatory bowel diseases (IBD) (83– 85), Crohn’s disease (CD) and ulcerative colitis (UC) (86), and asthma and…”
BackgroundSaladié, M., Caparros-Martin, J. A., Agudelo‐Romero, P., Wark, P. A. B., Stick, S. M., & O’Gara, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.572504 · Cited by 32
Lemieszek, M. K., Chilosi, M., Golec, M., Skórska, C., Huaux, F., Yakoub, Y., Pastena, C., Daniele, I., Cholewa, G., Sitkowska, J., et al. (2011) · PubMed · Cited by 30
Beck, J. M. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201306-188mg · Cited by 29
Macrophage migration inhibitory factor, a role in COPD
Husebø, G. R., Bakke, P. S., Grønseth, R., Hardie, J. A., Ueland, T., Aukrust, P., & Eagan, T. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00461.2015 · Cited by 35
The pulmonary microbiome: challenges of a new paradigm
Costa, A. N., da Costa, F. M., Campos, S. V., Salles, R. K., & Athanazio, R. A. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000209 · Cited by 40
“(37) In contrast, several studies of patients with COPD have revealed that their lung microbiome is clearly different from that of healthy controls.(39-42) In addition, among patients with COPD, depending on the site from which the material is collected, differences are also found in the composition of the microbiome,…”
BackgroundLi, X., Chen, M., Chen, T., Xie, L., Luo, Q., Fan, X., Yin, Y., Meng, S., Jin, Z., He, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06433-2 · Cited by 29
“…protein 1; Nsp13, non - structural protein 13; TBK1, TANK-binding kinase 1; PLPro, papain-like protease; ISG15, interferon-stimulated gene 15; IRF3, interferon regulatory factor 3; IAV, influenza A virus; IFNAR1, interferon-alpha / beta receptor 1; JAK, janus kinase; TYK2, tyrosine…”
Liu, H., Zheng, D., Lin, Y.-X., Liu, Z., Liang, Z., Su, J., Chen, R., Zhou, H., & Wang, Z. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105095 · Cited by 28
Data Mining of Lung Microbiota in Cystic Fibrosis Patients
Li, J., Hao, C., Ren, L., Xiao, Y. B., Wang, J., & Qin, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164510 · Cited by 30
Chakraborty, P., Banerjee, D., Majumder, P., & Sarkar, J. (2024) · Medicine in Microecology · doi:10.1016/j.medmic.2024.100104 · Cited by 29
Millares, L., Bermudo, G., Pérez‐Brocal, V., Domingo, C., García-Núñez, M., Pomares, X., Moyá, A., & Monsó, E. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0933-6 · Cited by 30
“cantly higher RA, a pattern that has been also reported for other severe chronic respiratory diseases such as COPD and CF [6, 8, 9], suggesting a common dysbiotic pattern in these obstructive diseases.”
BackgroundGosens, R., Hiemstra, P. S., Adcock, I. M., Bracke, K. R., Dickson, R. P., Hansbro, P. M., Krauss‐Etschmann, S., Smits, H. H., Stassen, F. R. M., & Bartel, S. (2020) · European Respiratory Journal · doi:10.1183/13993003.02320-2019 · Cited by 31
Metadata
- Authors
- Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C., & Isaacson, R. E.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Isaacson, Richard E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-11
- Volume
- 7
- Issue
- 10
- Pages
- e47305
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3469539
- OpenAlex
- W2077691383
- Cited by
- 437
- References
- 42
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 29 · 2023: 20 · 2022: 37 · 2021: 50 · 2020: 39 · 2019: 26 · 2018: 38 · 2017: 34 · 2016: 37 · 2015: 28 · 2014: 39 · 2013: 20 · 2012: 2
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Minnesota
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- National Institutes of Health (n01hr096140-001)
- University of Illinois at Urbana-Champaign
- National Heart, Lung, and Blood Institute (N01 HR096140, N010HR-96140)
- National Institute of Allergy and Infectious Diseases (T32AI55433, T32AI055433)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- lung microbiome, chronic obstructive pulmonary disease, COPD exacerbations, bronchoalveolar lavage fluid, microbial diversity, oral bacteria, inhaled corticosteroids, inhaled bronchodilators, disease severity, actinobacteria, Firmicutes, Proteobacteria
- MeSH terms
- Adult, Aged, Bronchoalveolar Lavage Fluid, Chronic Disease, Female, Humans, Lung, Male, Middle Aged, RNA, Ribosomal, 16S, Proteobacteria, Pulmonary Disease, Chronic Obstructive, Actinobacteria, Bacteroidetes, Fusobacteria, Metagenome, Acidobacteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.